Item Type | Name |
Concept
|
Platelet-Derived Growth Factor
|
Concept
|
Receptors, Androgen
|
Concept
|
Receptors, Estrogen
|
Concept
|
Tumor Necrosis Factor-alpha
|
Concept
|
Interferon-alpha
|
Concept
|
Receptor, IGF Type 1
|
Concept
|
Receptors, Transforming Growth Factor beta
|
Concept
|
Receptors, Calcitriol
|
Concept
|
Receptor, erbB-2
|
Concept
|
Estrogen Receptor alpha
|
Concept
|
Estrogen Receptor beta
|
Concept
|
Receptors, Scavenger
|
Concept
|
Receptors, CCR2
|
Academic Article
|
IGF gene polymorphisms and breast cancer in African-American and Hispanic women.
|
Academic Article
|
Expression of Wnt3 activates Wnt/?-catenin pathway and promotes EMT-like phenotype in trastuzumab-resistant HER2-overexpressing breast cancer cells.
|
Academic Article
|
Vitamin D receptor FokI gene polymorphisms may be associated with colorectal cancer among African American and Hispanic participants.
|
Academic Article
|
Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NF?B signaling.
|
Academic Article
|
Biologic roles of estrogen receptor-? and insulin-like growth factor-2 in triple-negative breast cancer.
|
Academic Article
|
Combined inhibition of glycolysis and AMPK induces synergistic breast cancer cell killing.
|
Academic Article
|
Identification of Novel Biomarkers for Metastatic Colorectal Cancer Using Angiogenesis-Antibody Array and Intracellular Signaling Array.
|
Academic Article
|
FOXO1A is a target for HER2-overexpressing breast tumors.
|
Academic Article
|
Triple negative breast tumors in African-American and Hispanic/Latina women are high in CD44+, low in CD24+, and have loss of PTEN.
|
Academic Article
|
STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits.
|
Academic Article
|
Enhanced inhibition of prostate cancer xenograft tumor growth by combining quercetin and green tea.
|
Academic Article
|
Constitutive activation of STAT3 signaling regulates hTERT and promotes stem cell-like traits in human breast cancer cells.
|
Academic Article
|
Vitamin D receptor gene polymorphisms and prognosis of breast cancer among African-American and Hispanic women.
|
Academic Article
|
Arctigenin in combination with quercetin synergistically enhances the antiproliferative effect in prostate cancer cells.
|
Academic Article
|
Slug contributes to cancer progression by direct regulation of ERa signaling pathway.
|
Academic Article
|
Activation of Akt1 accelerates carcinogen-induced tumorigenesis in mammary gland of virgin and post-lactating transgenic mice.
|
Academic Article
|
Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer.
|
Academic Article
|
Estrogen receptor-beta is a potential target for triple negative breast cancer treatment.
|
Academic Article
|
Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and S100 genes as targets.
|
Academic Article
|
Estrogen Receptor-? and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer.
|
Academic Article
|
Salinomycin Abolished STAT3 and STAT1 Interactions and Reduced Telomerase Activity in Colorectal Cancer Cells.
|
Academic Article
|
A83-01 inhibits TGF-?-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells.
|
Academic Article
|
Proinflammatory Cytokines IL-6 and TNF-a Increased Telomerase Activity through NF-?B/STAT1/STAT3 Activation, and Withaferin A Inhibited the Signaling in Colorectal Cancer Cells.
|
Academic Article
|
Arctigenin inhibits prostate tumor growth in high-fat diet fed mice through dual actions on adipose tissue and tumor.
|
Academic Article
|
CCL2/CCR2 signaling in cancer pathogenesis.
|
Academic Article
|
Basal-like breast cancer with low TGF? and high TNFa pathway activity is rich in activated memory CD4 T cells and has a good prognosis.
|
Academic Article
|
ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor-negative breast cancer patients.
|